Lilly to Complete $1.4 Billion Acquisition of Point Biopharma on Wednesday

Pharmaceutical giant Eli Lilly is expected to complete its $1.4 billion acquisition of radiopharmaceutical company POINT Biopharma Global Inc. on Wednesday, following the completion of its tender offer for POINT Biopharma. (Tencent Finance)Original Link